Problems and promises of targeted therapy for Hodgkin's lymphoma

Nat Clin Pract Oncol. 2005 Jan;2(1):2-3. doi: 10.1038/ncponc0073.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cell Transformation, Neoplastic
  • Gene Expression Profiling
  • Hodgkin Disease / drug therapy*
  • Hodgkin Disease / genetics
  • Hodgkin Disease / physiopathology
  • Humans
  • Prognosis
  • Risk Factors
  • Signal Transduction